"Over the past decade, CTTI has helped to make important strides in modernizing the clinical trials enterprise to be more streamlined, efficient, and patient-centered."
-Scott Gottlieb, MD, Commissioner, U.S. Food and Drug Administration
"In this report, we detail CTTI’s 2016 successes confronting leading challenges. We have developed evidence-based, consensus-driven recommendations to fuel meaningful changes in medical product development, such as enhanced participant recruitment strategies and approaches for more streamlined clinical trials of new antibacterial therapies. We also drove adoption of these recommendations to make better clinical trials a reality."
-Pamela Tenaerts, MD, MBA, Executive Director, CTTI